Edna Mozes

8.2k total citations
271 papers, 6.5k citations indexed

About

Edna Mozes is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Rheumatology. According to data from OpenAlex, Edna Mozes has authored 271 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 170 papers in Immunology, 132 papers in Radiology, Nuclear Medicine and Imaging and 82 papers in Rheumatology. Recurrent topics in Edna Mozes's work include Monoclonal and Polyclonal Antibodies Research (130 papers), T-cell and B-cell Immunology (122 papers) and Systemic Lupus Erythematosus Research (77 papers). Edna Mozes is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (130 papers), T-cell and B-cell Immunology (122 papers) and Systemic Lupus Erythematosus Research (77 papers). Edna Mozes collaborates with scholars based in Israel, United States and Norway. Edna Mozes's co-authors include Michael Sela, Heidy Zinger, Molly Dayan, G M Shearer, Zev Sthoeger, Amir Sharabi, Yehuda Shoenfeld, Shlomo Mendlovic, Boris Tartakovsky and Dinah S. Singer and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Edna Mozes

268 papers receiving 6.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edna Mozes Israel	44	3.9k	1.9k	1.8k	1.3k	496	271	6.5k
John Hardin United States	46	2.0k 0.5×	1.4k 0.7×	2.4k 1.4×	2.7k 2.1×	575 1.2×	122	7.6k
Paola Migliorini Italy	42	2.4k 0.6×	1.1k 0.6×	2.0k 1.1×	1.3k 1.0×	497 1.0×	183	5.2k
John H. Vaughan United States	37	1.6k 0.4×	1.1k 0.6×	1.2k 0.7×	966 0.7×	535 1.1×	138	5.0k
Martin E. Sanders United States	30	3.7k 1.0×	1.2k 0.7×	433 0.2×	862 0.7×	597 1.2×	65	6.1k
Thomas M. Chused United States	47	3.3k 0.8×	1.1k 0.6×	780 0.4×	1.5k 1.1×	537 1.1×	111	6.0k
Patricia J. McConahey United States	27	3.0k 0.8×	1.7k 0.9×	1.1k 0.6×	1.5k 1.2×	427 0.9×	42	5.7k
Yaakov Naparstek Israel	34	1.8k 0.5×	938 0.5×	1.0k 0.6×	1.0k 0.8×	260 0.5×	105	4.1k
P. J. Lachmann United Kingdom	50	4.6k 1.2×	1.2k 0.6×	922 0.5×	1.6k 1.2×	524 1.1×	201	8.0k
Pierre Galanaud France	44	4.4k 1.1×	675 0.4×	1.4k 0.8×	1.0k 0.8×	1.6k 3.3×	193	8.2k
Luís Eduardo Coelho Andrade Brazil	44	1.7k 0.4×	1.3k 0.7×	2.1k 1.2×	1.8k 1.4×	269 0.5×	244	6.5k

Countries citing papers authored by Edna Mozes

Since Specialization

Citations

This map shows the geographic impact of Edna Mozes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edna Mozes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edna Mozes more than expected).

Fields of papers citing papers by Edna Mozes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edna Mozes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edna Mozes. The network helps show where Edna Mozes may publish in the future.

Co-authorship network of co-authors of Edna Mozes

This figure shows the co-authorship network connecting the top 25 collaborators of Edna Mozes. A scholar is included among the top collaborators of Edna Mozes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edna Mozes. Edna Mozes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gertel, Smadar, Gidon Karmon, Eszter Szarka, et al.. (2018). Anticitrullinated Protein Antibodies Induce Inflammatory Gene Expression Profile in Peripheral Blood Cells from CCP–positive Patients with RA. The Journal of Rheumatology. 45(3). 310–319. 4 indexed citations

Sthoeger, Zev, Amir Sharabi, & Edna Mozes. (2014). Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus. Journal of Autoimmunity. 54. 60–71. 33 indexed citations

Sharabi, Amir, et al.. (2009). Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide. Journal of Autoimmunity. 34(2). 87–95. 20 indexed citations

Sthoeger, Zev, Amir Sharabi, Yair Molad, et al.. (2009). Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): Immunomodulation of gene expression. Journal of Autoimmunity. 33(1). 77–82. 44 indexed citations

Sharabi, Amir & Edna Mozes. (2008). The Suppression of Murine Lupus by a Tolerogenic Peptide Involves Foxp3-Expressing CD8 Cells That Are Required for the Optimal Induction and Function of Foxp3-Expressing CD4 Cells. The Journal of Immunology. 181(5). 3243–3251. 48 indexed citations

Sharabi, Amir, et al.. (2007). The Role of Apoptosis in the Ameliorating Effects of a CDR1-Based Peptide on Lupus Manifestations in a Mouse Model. The Journal of Immunology. 179(8). 4979–4987. 28 indexed citations

Sela, Uri, Rami Hershkoviz, Liora Cahalon, Ofer Lider, & Edna Mozes. (2005). Down-Regulation of Stromal Cell-Derived Factor-1α-Induced T Cell Chemotaxis by a Peptide Based on the Complementarity-Determining Region 1 of an Anti-DNA Autoantibody via Up-Regulation of TGF-β Secretion. The Journal of Immunology. 174(1). 302–309. 19 indexed citations

Rapoport, Micha J., Amir Sharabi, Dorit Aharoni, et al.. (2005). Amelioration of SLE-like manifestations in (NZBxNZW)F1 mice following treatment with a peptide based on the complementarity determining region 1 of an autoantibody is associated with a down-regulation of apoptosis and of the pro-apoptotic factor JNK kinase. Clinical Immunology. 117(3). 262–270. 42 indexed citations

Mozes, Edna, et al.. (2000). Progression from Acute to Chronic Disease in a Murine Parent-into-F1 Model of Graft-Versus-Host Disease. The Journal of Immunology. 165(10). 5987–5994. 46 indexed citations

10.

Lindner, Arie, et al.. (1999). Prostate-Specific Antigen Induces Proliferation of Peripheral Blood Lymphocytes and Cytokine Secretion in Benign Prostate Hypertrophy Patients. European Urology. 36(3). 258–265. 4 indexed citations

11.

Mozes, Edna, et al.. (1998). Spontaneous Autoimmune Disease in (NZB × NZW)F1 Mice is Ameliorated by Treatment with Methimazole. Journal of Clinical Immunology. 18(2). 106–113. 18 indexed citations

12.

Mittleman, Barbara B., Herbert C. Morse, Susan Payne, Gene M. Shearer, & Edna Mozes. (1996). Amelioration of experimental systemic lupus erythematosus (SLE) by retrovirus infection. Journal of Clinical Immunology. 16(4). 230–236. 9 indexed citations

13.

Tartakovsky, Boris, Bonnie L. Bermas, Zev Sthoeger, G M Shearer, & Edna Mozes. (1996). Immunology: Defective maternal--fetal interaction in a murine autoimmune model. Human Reproduction. 11(11). 2408–2411. 34 indexed citations

14.

Bermas, Bonnie L., Michelle Petri, Jay A. Berzofsky, et al.. (1994). Binding of Glycoprotein 120 and Peptides from the HIV-1 Envelope by Autoantibodies in Mice with Experimentally Induced Systemic Lupus Erythematosus and in Patients with the Disease. AIDS Research and Human Retroviruses. 10(9). 1071–1077. 25 indexed citations

15.

Zinger, Heidy, et al.. (1991). Regulatory T cell activity specific to human type II and III collagens in rheumatoid arthritis.. PubMed. 18(4). 516–21. 12 indexed citations

16.

Blank, Miri, Margalit Krup, Shlomo Mendlovic, et al.. (1990). The Importance of the Pathogenic 16/6 Idiotype in the Induction of SLE in Naive Mice. Scandinavian Journal of Immunology. 31(1). 45–52. 45 indexed citations

17.

Segal, Raphael, Chaim Brautbar, Douglas I. Katz, et al.. (1986). Analysis of antigen specific T cell helper function in first degree relatives of patients with systemic lupus erythematosus (SLE).. PubMed Central. 66(1). 52–60. 3 indexed citations

18.

Strassmann, Gideon, Zelig Eshhar, & Edna Mozes. (1980). Genetic regulation of delayed-type hypersensitivity responses to poly(LTyr,LGlu)-poly(DLAla)--poly(LLys). II. Evidence for a T-T-cell collaboration in delayed-type hypersensitivity responses and for a T-cell defect at the efferent phase in nonresponder H-2k mice.. The Journal of Experimental Medicine. 151(3). 628–636. 23 indexed citations

19.

Mozes, Edna, et al.. (1975). Genetic control of immune response. The dose of antigen given in aqueous solution is critical in determining which mouse strain is high responder to poly(LTyr, LGlu)-poly(LPro)--poly(LLys).. The Journal of Experimental Medicine. 141(5). 1057–1072. 13 indexed citations

20.

Mozes, Edna, Hugh O. McDevitt, Jean‐Claude Jaton, & Michael Sela. (1969). THE GENETIC CONTROL OF ANTIBODY SPECIFICITY. The Journal of Experimental Medicine. 130(6). 1263–1278. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact